---
title: "Canopy Growth Corp SEC 10-Q Report"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/275120637.md"
description: "Canopy Growth Corp has released its Form 10-Q report for the quarter ending December 31, 2025. Key financial metrics include revenue of $90.391 million, a slight increase from $86.244 million in 2024, and a net loss of $(62.627) million, significantly reduced from $(121.896) million in the same period of 2024. The report highlights stable sales performance in the Cannabis segment, while the Storz & Bickel segment focuses on vaporizers. The company aims to optimize operations and expand market presence, considering potential regulatory changes in the U.S."
datetime: "2026-02-06T11:51:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/275120637.md)
  - [en](https://longbridge.com/en/news/275120637.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/275120637.md)
---

# Canopy Growth Corp SEC 10-Q Report

Canopy Growth Corp, a leading player in the cannabis industry, has released its Form 10-Q report for the quarter ending December 31, 2025. The report provides a comprehensive overview of the company's financial performance and operational highlights, reflecting its ongoing efforts to optimize operations and expand market presence.

**Financial Highlights**

Canopy Growth Corp reported the following key financial metrics for the three months ended December 31, 2025:

-   **Revenue**: $90.391 million, reflecting a slight increase from $86.244 million in the same period of 2024.
-   **Net Revenue**: $74.541 million, compared to $74.761 million in the same period of 2024, indicating stable sales performance.
-   **Gross Margin**: $21.466 million, down from $24.098 million in the same period of 2024, highlighting a decrease in profitability.
-   **Operating Loss from Continuing Operations**: $(26.350) million, compared to $(23.822) million in the same period of 2024, showing an increase in operating losses.
-   **Net Loss from Continuing Operations**: $(62.627) million, compared to $(121.896) million in the same period of 2024, indicating a significant reduction in net losses.
-   **Basic and Diluted Loss Per Share**: $(0.18), compared to $(1.11) in the same period of 2024, reflecting an improvement in per-share loss.

**Business Highlights**

The company's business performance for the quarter included the following highlights:

-   **Revenue Segments**: Canopy Growth Corp reported segmented net revenue from two main segments: Cannabis and Storz & Bickel. The Cannabis segment includes global production, distribution, and sale of cannabis and cannabis-related products, while the Storz & Bickel segment focuses on vaporizers and accessories.
-   **Geographical Performance**: The Cannabis segment's revenue is derived from Canadian adult-use and medical cannabis markets, as well as international markets. Canadian adult-use cannabis saw an increase in net revenue, while international markets cannabis experienced a decline.
-   **Future Outlook**: The company is focused on optimizing its operations and expanding its market presence, particularly in the cannabis segment. Management is also evaluating the impact of potential regulatory changes in the U.S. market, which could influence future operations and strategy.

SEC Filing: Canopy Growth Corp \[ CGC \] - 10-Q - Feb. 06, 2026

### Related Stocks

- [FLGC.US](https://longbridge.com/en/quote/FLGC.US.md)
- [CNGL.US](https://longbridge.com/en/quote/CNGL.US.md)
- [CGC.US](https://longbridge.com/en/quote/CGC.US.md)

## Related News & Research

- [Earnings Breakdown: Canopy Growth Q3](https://longbridge.com/en/news/275122188.md)
- [What's Going On With Canopy Growth Stock Thursday?](https://longbridge.com/en/news/283853966.md)
- [Canopy Growth (TSE:WEED) Stock Price Down 9.5%  - Time to Sell?](https://longbridge.com/en/news/283879573.md)
- [ZAWYA-PROJECTS: Kuwait’s CGC secures variation for Jurassic contract](https://longbridge.com/en/news/281034368.md)
- [Canopy Growth’s Apollo Clinics Named Top Medical Cannabis Provider by Toronto Star Readers](https://longbridge.com/en/news/281022430.md)